Tepezza For Thyroid Eye Disease Gets FDA Approval
The U.S. Food and Drug Administration (FDA) has granted Horizon Therapeutics Ireland DAC approval for teprotumumab-trbw as treatment in adults with thyroid eye disease, a rare condition where the…